Print Page  Close Window

News Release

Zogenix to Release First Quarter 2016 Financial Results and Host Conference Call and Webcast on May 10

EMERYVILLE, Calif., May 03, 2016 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing therapies for the treatment of central nervous system (CNS) disorders, today announced that it will report its financial results for the first quarter ended March 31, 2016 after the market close, and will host a corporate update conference call and webcast on Tuesday, May 10th, at 4:30 PM Eastern Time.

Tuesday, May 10th @ 4:30 PM Eastern Time/1:30 PM Pacific Time
Toll Free: 888-576-4398
International: 719-457-2727
Conference ID:       6099104
Webcast: http://public.viavid.com/index.php?id=119074
   
Replays, available through May 24:
Domestic: 877-870-5176
International: 858-384-5517
Replay PIN: 6099104
   

About Zogenix
Zogenix, Inc. (NASDAQ:ZGNX) is an innovative pharmaceutical company committed to providing unique therapeutic solutions for people living with rare and burdensome disease conditions. Our focused strategy centers on advancing late-stage, high-value products for CNS disorders that will significantly improve outcomes for patients and physicians.

For more information, visit www.zogenix.com.

CONTACT:
Investors: Andrew McDonald
Founding Partner, LifeSci Advisors LLC
646-597-6987 | Andrew@lifesciadvisors.com

Zogenix, Inc.